Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Retatrutide is currently undergoing Phase III clinical trials, representing the final stage of clinical development before potential regulatory approval
Indeed, our previous findings revealed that silencing CDCA7 , a gene overexpressed in lymphoid tumors, specifically inhibited cell growth in 3D gels, without inhibiting proliferation in 2D conditions, and reduced lymphoma growth in vivo and tumor cell migration and invasion [32, 37]
doi: 10.1073/pnas.85.10.3653
Manufactured with trusted ingredients in quality-controlled facilities
US$ 28.27
US$ 23.46
US$ 26.69
US$ 26.99
US$ 28.92
